A truncated form of the hiv p17 protein

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/21 (2006.01) C07K 14/16 (2006.01)

Patent

CA 2711930

The invention relates to a truncated form of the HIV-1 p17 protein, designated as AT96, which consists of the residues from 1 to 96 of the full-length p17 protein, as well as the corresponding nucleic acid sequences. The truncated AT96 protein has the same immunological features as the full-length p17 protein but at the same time is devoid of the typical detrimental biological activities of the HIV-1 p17 protein.

L'invention concerne une forme tronquée de la protéine p17 du VIH-1, appelée AT96, constituée par les résidus 1 à 96 de la protéine p17 pleine longueur, ainsi que les séquences d'acides nucléiques correspondantes. La protéine AT96 tronquée présente les mêmes caractéristiques immunologiques que la protéine p17 pleine longueur mais ne présente pas les activités biologiques néfastes typiques de la protéine p17 du VIH-1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A truncated form of the hiv p17 protein does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A truncated form of the hiv p17 protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A truncated form of the hiv p17 protein will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1967137

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.